Todos Medical Ltd. of Rehovot at MEDICA 2019 in Düsseldorf -- MEDICA - World Forum for Medicine

Todos Medical Ltd.

1, Hamada St., 7670301 Rehovot
Israel
Telephone +972 8 633964
Fax +972 8 633964
info@todosmedical.com

This company is co-exhibitor of
Israel Export & International Cooperation Institute

Hall map

MEDICA 2019 hall map (Hall 16): stand M25

Fairground map

MEDICA 2019 fairground map: Hall 16

Our range of products

Product categories

  • 03  Diagnostic Tests
  • 03.07  Other diagnostics

Our products

Product category: Other diagnostics

Todos Breast Screens (TM-B1, TM-B2)

Our breast cancer blood Test is targeting a large population of women that need to be checked regularly for breast cancer, whether that is because of a high risk group or at an age that women are routinely screened. Usually all women above 40 years old undergo a breast testing. The recommended testing protocol using Mammography and Ultrasound have their limitations and discomfort. Our proprietary TM-B1 cancer test will support current cancer diagnostic protocols in their weak points (like dense breast tissue and young woman) and give a simple and low-cost solution for early detection. Our proprietary TM-B2 cancer screen will allow health care providers to distinguish between benign and malignant breast tumors.

Latest Clinical Data
Todos Medical has collected over 1,000 clinical samples in several clinical trials for breast and other cancers at the Wolfson Medical Center (Holon, Israel), Rabin Medical Center (Petach Tikva, Israel), Ichilov Medical center (Tel Aviv, Israel) and in the Ukraine. The latest clinical trial (link to article in publication section) for Todos Medical’s breast cancer test included 59 patients and achieved 93% sensitivity and 87% specificity as compared to routine mammography screening.

More Less

Product category: Other diagnostics

Todos Colon (TM-C1)

Colonoscopy is the current standard in Colorectal Cancer (CRC) testing. Our proprietary TM-C1 cancer test is targeting the detection of colorectal cancers at an early stage. A large percentage of patients (40% or higher) who have been recommended to undergo a colonoscopy do not get one (mainly due to discomfort and cost). Our TM-C1 test is a groundbreaking cancer test that will indicate the presence of colon cancer. As it is a blood test, it is minimally invasive and affordable. If colon cancer is detected, the physician can then determine appropriate next steps. TM-C1 is not intended to replace colonoscopies or other standard diagnostic methods. Our goal is to incorporate our TM-C1 test into the current colon cancer screening protocols in order to save lives by improving early detection.

 Latest Clinical Data
Todos Medical has collected over 1,000 clinical samples in several clinical trials for breast and other cancers at the Wolfson Medical Center (Holon, Israel), Rabin Medical Center (Petach Tikva, Israel), Ichilov Medical center (Tel Aviv, Israel) and in the Ukraine. The latest clinical trial (link to article in publication section) for Todos Medical’s colorectal cancer test included 64 patients and achieved 82% sensitivity and 91% specificy as compared to colonoscopy screening.

More Less

About us

Company details

Todos Medical aims to develop and bring to market its revolutionary blood tests for cancer detection.

Our new cancer test will add a layer to currently available cancer screening and diagnostics.
Our goal is to help save lives through early detection while being minimally invasive to the patient.

  • Todos Medical’s vision is to become the standard of care in the way people are routinely checked for cancer (early detection).
  • The new method is easy to implement and at a low cost, currently targeting the mass population as the first choice for cancer detection.
  • The technology is a platform, and we are investigating methods for using our platform on other types of cancers (as a start we are focused on breast and colon cancers).

More Less